The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-κB through its N-terminal fragment

被引:120
作者
Chae, Jae Jin [1 ]
Wood, Geryl [1 ]
Richard, Katharina [1 ]
Jaffe, Howard [2 ]
Colburn, Nona T. [1 ]
Masters, Seth L. [1 ]
Gumucio, Deborah L. [3 ]
Shoham, Nitza G. [1 ]
Kastner, Daniel L. [1 ]
机构
[1] NIAMSD, Genet & Genom Branch, Bethesda, MD 20892 USA
[2] Natl Inst Neurol Disorders & Stroke, Prot Peptide Sequencing Facil, Bethesda, MD 20892 USA
[3] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA
关键词
D O I
10.1182/blood-2008-01-134932
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Familial Mediterranean fever (FMF) is an autoinflammatory disease caused by mutations in MEFV which encodes a 781-amino acid protein denoted pyrin. We have previously shown that pyrin regulates caspase-1 activation and IL-1 beta production through interaction of its N-terminal PYD motif with the ASC adapter protein, and also modulates IL-1 beta production by interaction of its C-terminal B30.2 domain with the catalytic domains of caspase-1. We now asked whether pyrin might itself be a caspase-1 substrate, and found that pyrin is cleaved by caspase-1 at Asp330, a site remote from the B30.2 domain. Pyrin variants harboring FMF-associated B30.2 mutations were cleaved more efficiently than wild-type pyrin. The N-terminal cleaved fragment interacted with the p65 subunit of NF-kappa B and with I kappa B-alpha through its 15-aa bZIP basic domain and adjacent sequences, respectively, and translocated to the nucleus. The interaction of the N-terminal fragment with p65 enhanced entrance of p65 into the nucleus. The interaction of N-terminal pyrin with I kappa B-alpha induced calpain-mediated degradation of I kappa B-alpha, thus potentiating NF-kappa B activation. Absolute and relative quantities of cleaved pyrin and I kappa B-alpha degradation products were substantially increased in leukocytes from FMF patients compared with healthy controls. Our data support a new pyrin/caspase-1 pathway for NF-kappa B activation.
引用
收藏
页码:1794 / 1803
页数:10
相关论文
共 65 条
  • [1] NALP3 forms an IL-lβ-Processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder
    Agostini, L
    Martinon, F
    Burns, K
    McDermott, MF
    Hawkins, PN
    Tschopp, J
    [J]. IMMUNITY, 2004, 20 (03) : 319 - 325
  • [2] Aksentijevich I, 1997, CELL, V90, P797
  • [3] Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IκBα/NF-κB pathway in limb-girdle muscular dystrophy type 2A
    Baghdiguian, S
    Martin, M
    Richard, I
    Pons, F
    Astier, C
    Bourg, N
    Hay, RT
    Chemaly, R
    Halaby, G
    Loiselet, J
    Anderson, LVB
    de Munain, AL
    Fardeau, M
    Mangeat, P
    Beckmann, JS
    Lefranc, G
    [J]. NATURE MEDICINE, 1999, 5 (05) : 503 - 511
  • [4] Pyrin-only protein 2 modulates NFκB and disrupts ASC:CLR interactions
    Bedoya, Felipe
    Sandler, Laurel L.
    Harton, Jonathan A.
    [J]. JOURNAL OF IMMUNOLOGY, 2007, 178 (06) : 3837 - 3845
  • [5] Bernot A, 1997, NAT GENET, V17, P25
  • [6] The PYRIN domain: a novel motif found in apoptosis and inflammation proteins
    Bertin, J
    DiStefano, PS
    [J]. CELL DEATH AND DIFFERENTIATION, 2000, 7 (12) : 1273 - 1274
  • [7] Cleavage of PITSLRE kinases by ICE/CASP-1 and CPP32/CASP-3 during apoptosis induced by tumor necrosis factor
    Beyaert, R
    Kidd, VJ
    Cornelis, S
    VandeCraen, M
    Denecker, G
    Lahti, JM
    Gururajan, R
    Vandenabeele, P
    Fiers, W
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (18) : 11694 - 11697
  • [8] BLACK RA, 1988, J BIOL CHEM, V263, P9437
  • [9] PAN1/NALP2/PYPAF2, an inducible inflammatory mediator that regulates NF-κB and caspase-1 activation in macrophages
    Bruey, JM
    Bruey-Sedano, N
    Newman, R
    Chandler, S
    Stehlik, C
    Reed, JC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (50) : 51897 - 51907
  • [10] Familial mediterranean fever among patients from Karabakh and the diagnostic value of MEFV gene analysis in all classically affected populations
    Cazeneuve, C
    Hovannesyan, Z
    Geneviève, D
    Hayrapetyan, H
    Papin, S
    Girodon-Boulandet, E
    Boissier, B
    Feingold, J
    Atayan, K
    Sarkisian, T
    Amselem, S
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (08): : 2324 - 2331